Latest Market Share News

Skin Elements Limited has completed a $2.5 million placement to fund the commercial rollout of its ECO Nurture bio-stimulant, targeting sustainable kiwifruit orchard protection in New Zealand.

Duxton Farms Limited has initiated an on-market share buyback program, aiming to repurchase up to 10% of its issued capital to support liquidity and enhance shareholder returns.

The ACCC has opposed IAG’s proposed acquisition of RAC Insurance in Western Australia, citing concerns it would stifle competition and lead to higher premiums and reduced product quality.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

Cogstate Ltd reports a near doubling in sales contracts for the first half of 2026 but warns of timing-related revenue deferrals that will temper short-term earnings. Despite this, management remains optimistic about medium- and long-term growth prospects.

Symal Group has agreed to acquire Timms Group and L&D Contracting for $28 million, significantly expanding its Queensland footprint and positioning itself for the 2032 Brisbane Olympics infrastructure boom.

Bapcor Limited has revised its first-half FY26 guidance to a statutory net loss, citing weaker trade segment performance and one-off costs, while maintaining a cautiously optimistic full-year outlook supported by cost savings and leadership changes.

Australian Vintage Limited has secured a five-year distribution agreement to represent Invivo's wine portfolio in the UK and Ireland, promising significant revenue and volume growth.

Premier Investments Limited has announced an on-market share buy-back program valued up to $100 million AUD, set to commence in late December 2025 and run through 2026.

Premier Investments reported a robust FY25 with a 31% rise in net profit, driven by strong performances from Peter Alexander and Smiggle, alongside a strategic capital return plan including a $100 million share buyback.

DorsaVi reports significant progress in its resistive RAM (RRAM) development, optimizing memory technology for integration with neuromorphic computing at the 22nm technology node. This advancement positions the company to deliver energy-efficient edge-AI solutions for wearables, robotics, and industrial safety.

Anteris Technologies has secured regulatory green lights for its pivotal PARADIGM trial and raised $25.2 million in capital, advancing its innovative DurAVR® transcatheter heart valve towards commercialisation.